Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 3 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 4 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000815 | ESCRT III complex | 3 | 8 |
GO:0016363 | nuclear matrix | 2 | 8 |
GO:0032991 | protein-containing complex | 1 | 8 |
GO:0036452 | ESCRT complex | 2 | 8 |
GO:0098796 | membrane protein complex | 2 | 8 |
GO:0110165 | cellular anatomical entity | 1 | 8 |
GO:0005768 | endosome | 7 | 1 |
GO:0005770 | late endosome | 8 | 1 |
GO:0005771 | multivesicular body | 9 | 1 |
GO:0031410 | cytoplasmic vesicle | 6 | 1 |
GO:0031982 | vesicle | 4 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0097708 | intracellular vesicle | 5 | 1 |
Related structures:
AlphaFold database: A4HLQ2
Term | Name | Level | Count |
---|---|---|---|
GO:0006810 | transport | 3 | 12 |
GO:0006996 | organelle organization | 4 | 8 |
GO:0007034 | vacuolar transport | 4 | 12 |
GO:0007076 | mitotic chromosome condensation | 4 | 8 |
GO:0009987 | cellular process | 1 | 12 |
GO:0016043 | cellular component organization | 3 | 8 |
GO:0016192 | vesicle-mediated transport | 4 | 8 |
GO:0022402 | cell cycle process | 2 | 8 |
GO:0030261 | chromosome condensation | 6 | 8 |
GO:0046907 | intracellular transport | 3 | 12 |
GO:0051179 | localization | 1 | 12 |
GO:0051234 | establishment of localization | 2 | 12 |
GO:0051276 | chromosome organization | 5 | 8 |
GO:0051641 | cellular localization | 2 | 12 |
GO:0051649 | establishment of localization in cell | 3 | 12 |
GO:0071840 | cellular component organization or biogenesis | 2 | 8 |
GO:1903047 | mitotic cell cycle process | 3 | 8 |
GO:0008104 | protein localization | 4 | 1 |
GO:0015031 | protein transport | 4 | 1 |
GO:0016197 | endosomal transport | 4 | 1 |
GO:0032509 | endosome transport via multivesicular body sorting pathway | 5 | 1 |
GO:0033036 | macromolecule localization | 2 | 1 |
GO:0045184 | establishment of protein localization | 3 | 1 |
GO:0045324 | late endosome to vacuole transport | 5 | 1 |
GO:0070727 | cellular macromolecule localization | 3 | 1 |
GO:0071702 | organic substance transport | 4 | 1 |
GO:0071705 | nitrogen compound transport | 4 | 1 |
GO:0071985 | multivesicular body sorting pathway | 5 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 116 | 120 | PF00656 | 0.256 |
CLV_C14_Caspase3-7 | 150 | 154 | PF00656 | 0.174 |
CLV_C14_Caspase3-7 | 73 | 77 | PF00656 | 0.256 |
CLV_NRD_NRD_1 | 184 | 186 | PF00675 | 0.616 |
CLV_NRD_NRD_1 | 59 | 61 | PF00675 | 0.315 |
CLV_PCSK_KEX2_1 | 61 | 63 | PF00082 | 0.310 |
CLV_PCSK_PC1ET2_1 | 61 | 63 | PF00082 | 0.310 |
CLV_PCSK_SKI1_1 | 113 | 117 | PF00082 | 0.449 |
CLV_PCSK_SKI1_1 | 19 | 23 | PF00082 | 0.332 |
CLV_PCSK_SKI1_1 | 40 | 44 | PF00082 | 0.302 |
CLV_PCSK_SKI1_1 | 89 | 93 | PF00082 | 0.375 |
DEG_SPOP_SBC_1 | 94 | 98 | PF00917 | 0.174 |
DOC_USP7_MATH_1 | 25 | 29 | PF00917 | 0.345 |
DOC_USP7_MATH_1 | 77 | 81 | PF00917 | 0.310 |
DOC_USP7_UBL2_3 | 100 | 104 | PF12436 | 0.269 |
DOC_USP7_UBL2_3 | 15 | 19 | PF12436 | 0.334 |
DOC_USP7_UBL2_3 | 170 | 174 | PF12436 | 0.174 |
DOC_USP7_UBL2_3 | 30 | 34 | PF12436 | 0.288 |
DOC_USP7_UBL2_3 | 41 | 45 | PF12436 | 0.323 |
DOC_USP7_UBL2_3 | 89 | 93 | PF12436 | 0.388 |
LIG_14-3-3_CanoR_1 | 113 | 118 | PF00244 | 0.174 |
LIG_14-3-3_CanoR_1 | 81 | 90 | PF00244 | 0.368 |
LIG_DLG_GKlike_1 | 62 | 69 | PF00625 | 0.225 |
LIG_FHA_1 | 125 | 131 | PF00498 | 0.315 |
LIG_FHA_1 | 144 | 150 | PF00498 | 0.323 |
LIG_FHA_2 | 114 | 120 | PF00498 | 0.293 |
LIG_FHA_2 | 148 | 154 | PF00498 | 0.407 |
LIG_LIR_Gen_1 | 65 | 75 | PF02991 | 0.200 |
LIG_LIR_Nem_3 | 65 | 71 | PF02991 | 0.200 |
LIG_Pex14_2 | 12 | 16 | PF04695 | 0.338 |
LIG_PTB_Apo_2 | 10 | 17 | PF02174 | 0.449 |
LIG_SH2_STAP1 | 54 | 58 | PF00017 | 0.310 |
LIG_SH2_STAT5 | 68 | 71 | PF00017 | 0.310 |
LIG_TYR_ITIM | 66 | 71 | PF00017 | 0.345 |
LIG_UBA3_1 | 10 | 19 | PF00899 | 0.314 |
MOD_CK1_1 | 142 | 148 | PF00069 | 0.308 |
MOD_CK1_1 | 28 | 34 | PF00069 | 0.294 |
MOD_CK2_1 | 151 | 157 | PF00069 | 0.339 |
MOD_GlcNHglycan | 142 | 145 | PF01048 | 0.304 |
MOD_GlcNHglycan | 166 | 170 | PF01048 | 0.355 |
MOD_GlcNHglycan | 23 | 26 | PF01048 | 0.310 |
MOD_GlcNHglycan | 29 | 33 | PF01048 | 0.310 |
MOD_GSK3_1 | 139 | 146 | PF00069 | 0.318 |
MOD_GSK3_1 | 147 | 154 | PF00069 | 0.336 |
MOD_GSK3_1 | 15 | 22 | PF00069 | 0.314 |
MOD_GSK3_1 | 165 | 172 | PF00069 | 0.139 |
MOD_GSK3_1 | 77 | 84 | PF00069 | 0.365 |
MOD_GSK3_1 | 89 | 96 | PF00069 | 0.189 |
MOD_N-GLC_1 | 140 | 145 | PF02516 | 0.174 |
MOD_N-GLC_1 | 62 | 67 | PF02516 | 0.225 |
MOD_NEK2_1 | 139 | 144 | PF00069 | 0.323 |
MOD_NEK2_1 | 176 | 181 | PF00069 | 0.710 |
MOD_NEK2_1 | 21 | 26 | PF00069 | 0.344 |
MOD_NEK2_1 | 95 | 100 | PF00069 | 0.297 |
MOD_PKB_1 | 60 | 68 | PF00069 | 0.225 |
MOD_Plk_1 | 62 | 68 | PF00069 | 0.216 |
MOD_Plk_2-3 | 151 | 157 | PF00069 | 0.200 |
MOD_Plk_4 | 113 | 119 | PF00069 | 0.174 |
MOD_Plk_4 | 151 | 157 | PF00069 | 0.310 |
TRG_DiLeu_BaEn_1 | 151 | 156 | PF01217 | 0.345 |
TRG_ENDOCYTIC_2 | 68 | 71 | PF00928 | 0.302 |
TRG_ER_diArg_1 | 59 | 62 | PF00400 | 0.310 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I2G2 | Leptomonas seymouri | 49% | 100% |
A0A0N1IMC7 | Leptomonas seymouri | 75% | 100% |
A0A0S4IQI9 | Bodo saltans | 65% | 96% |
A0A0S4JPB9 | Bodo saltans | 45% | 100% |
A0A1X0P5A2 | Trypanosomatidae | 45% | 99% |
A0A3Q8IGX6 | Leishmania donovani | 86% | 100% |
A0A3R7NNK8 | Trypanosoma rangeli | 43% | 99% |
A0A3S7X9V9 | Leishmania donovani | 46% | 99% |
A0A422N603 | Trypanosoma rangeli | 64% | 97% |
A4HNA9 | Leishmania braziliensis | 47% | 100% |
A4I952 | Leishmania infantum | 86% | 100% |
A4IBY0 | Leishmania infantum | 46% | 99% |
C9ZYM6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 43% | 99% |
D0A6C2 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 47% | 82% |
E9AFR7 | Leishmania major | 46% | 100% |
E9B427 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 85% | 100% |
E9B6X0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 46% | 99% |
O60074 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 43% | 100% |
O96552 | Dictyostelium discoideum | 41% | 100% |
P69771 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 42% | 100% |
Q3SX42 | Bos taurus | 30% | 96% |
Q4Q3Z7 | Leishmania major | 84% | 100% |
Q54DB1 | Dictyostelium discoideum | 25% | 100% |
Q5E994 | Bos taurus | 40% | 100% |
Q5F3A2 | Gallus gallus | 28% | 95% |
Q5R605 | Pongo abelii | 47% | 100% |
Q5RAV2 | Pongo abelii | 29% | 96% |
Q5ZKX1 | Gallus gallus | 40% | 100% |
Q66IV6 | Xenopus laevis | 27% | 95% |
Q6DF27 | Xenopus tropicalis | 41% | 100% |
Q6NUD8 | Xenopus laevis | 46% | 100% |
Q6NVL7 | Xenopus tropicalis | 26% | 95% |
Q6NXD2 | Danio rerio | 26% | 95% |
Q6PHF0 | Danio rerio | 45% | 100% |
Q7LBR1 | Homo sapiens | 40% | 100% |
Q7SYR0 | Xenopus laevis | 24% | 95% |
Q7SZB5 | Xenopus laevis | 41% | 100% |
Q7ZVB1 | Danio rerio | 41% | 100% |
Q84VG1 | Oryza sativa subsp. japonica | 42% | 100% |
Q8BJF9 | Mus musculus | 30% | 96% |
Q8LE58 | Arabidopsis thaliana | 43% | 100% |
Q921W0 | Mus musculus | 47% | 100% |
Q941D5 | Arabidopsis thaliana | 28% | 97% |
Q99LU0 | Mus musculus | 40% | 100% |
Q9CQD4 | Mus musculus | 40% | 100% |
Q9HD42 | Homo sapiens | 47% | 100% |
Q9SKI2 | Arabidopsis thaliana | 28% | 91% |
Q9SSM4 | Arabidopsis thaliana | 43% | 100% |
Q9UQN3 | Homo sapiens | 29% | 96% |